BBP

Virtus LifeSci Biotech Products ETF
NYSEARCA

Real-time Quotes | Provided by Morningstar

48.50
-0.05
-0.11%
Closed 16:00 07/10 EDT
OPEN
48.73
PREV CLOSE
48.55
HIGH
48.73
LOW
48.50
VOLUME
739
TURNOVER
--
52 WEEK HIGH
49.50
52 WEEK LOW
30.83
TOTAL ASSET
27.01M
YTD YIELD
11.20%
1D
5D
1M
3M
1Y
5Y

BBP News

More
Biotechnology Innovation During COVID-19
Seeking Alpha - Article · 06/11 07:47
ACADIA Pharmaceuticals: The Worst-Case Scenario For Investors
Seeking Alpha - Article · 06/08 00:01
ACADIA: The Company's Perspectives In Numbers.
Seeking Alpha - Article · 05/15 15:18
Will These Tech Stock Valuations Last?
Seeking Alpha - Article · 02/13 13:06
Should Investors Avoid U.S. Healthcare Stocks In An Election Year?
Seeking Alpha - Article · 02/10 14:35
Brookfield Asset Management: Strong And Getting Stronger
Seeking Alpha - Article · 10/06/2019 13:28
Aprea Therapeutics upsizes IPO amid turbulent biotech market
Seeking Alpha - Article · 10/03/2019 14:09

Profile

Fund Name
Virtus LifeSci Biotech Products ETF
Risk
High Risk
Inception Date
2014-12-16
Benchmark
LifeSci Biotechnology Products TR USD*100.0%
Advisor Company
Virtus
Custodian
The Bank of New York Mellon
Manager
Matthew Brown, Seth Kadushin

Asset Allocation

26.20M
  • 98.5175%
  • 0.00%
  • 1.4824%
  • 0.00%

2020 Q2

26.20M

2020 Q1

22.53M

2019 Q4

28.26M

2019 Q2

34.98M

2019 Q1

38.09M

Dividend History

Ex-Div Date
Dividend Per Share
12/20/2017
0.0723
12/21/2015
0.3970